Opinion: Needed: a clearer explanation of why diversity in clinical trials is important

Increasing the diversity of clinical trial participants is all the rage these days. The numbers tell the story: According to Food and Drug Administration data, in 2020 75% of trial participants were white, 11% were Hispanic, 8% were Black, and 6% were Asian. Given those numbers, regulators and sponsors are trying to broaden the recruitment of people from different racial and ethnic groups.

But one thing is missing: a clear explanation of why this is important.

Read the rest…

Read Original Article: Opinion: Needed: a clearer explanation of why diversity in clinical trials is important »